You are in: eMedicine Specialties >
Emergency Medicine > EAR, NOSE, AND THROAT
Epiglottitis, Adult
Article Last Updated: Dec 11, 2006
AUTHOR AND EDITOR INFORMATION
Section 1 of 11
Author: Jeffrey Glenn Bowman, MD, MS, Consulting Staff, Highfield MRI, Columbus, Ohio
Editors: Debra Slapper, MD, Consulting Staff, Department of Emergency Medicine, St Anthony's Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Mark W Fourre, MD, Program Director, Department of Emergency Medicine, Maine Medical Center; Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Pamela L Dyne, MD, Associate Professor, Program Director, Department of Medicine, Division of Emergency Medicine, University of California at Los Angeles School of Medicine
Author and Editor Disclosure
Synonyms and related keywords:
epiglottitis, inflammation of the epiglottis, sudden airway obstruction, Haemophilus influenzae B vaccine, H influenzae, Haemophilus influenzae type B, Hib vaccine, Hib vaccination
Background
Epiglottitis is an acute inflammation in the supraglottic region of the oropharynx with inflammation of the epiglottis, vallecula, arytenoids, and aryepiglottic folds.
George Washington probably died of epiglottitis in 1799.
Pathophysiology
Epiglottitis is an acute inflammation involving the epiglottis, vallecula, aryepiglottic folds, and arytenoids.
Frequency
United States
Epiglottitis is an uncommon disease. Incidence in adults is about 1 case per 100,000 per year. Adult epiglottitis is most frequently a disease of men, occurring during the fifth decade of life. The ratio of incidence in children to adults was 2.6:1 in 1980 and dropped to 0.4:1 in 1993. Occurrence has decreased since introduction of the Haemophilus influenzae B vaccine. However, vaccine failures are possible.
International
Epiglottitis is generally more common in nations that do not immunize against H influenzae type B. For example, in Sweden from 1987-1989, incidence was 14.7 per 100,000 people per year in children aged 0-4 years and 3.2 per 100,000 people per year overall. A large-scale Hib vaccination program in 1992-1993 resulted in a substantial decrease in Swedish cases of acute epiglottitis.
A retrospective review from the tropical country of Singapore over 8 years, ending in 1999, demonstrated 32 cases of acute epiglottitis, only 1 of which occurred in a child. During this time, Hib immunization was not routine, so Hib immunization cannot be used to explain the increased adult epiglottitis prevalence found in this study.
Mortality/Morbidity
- Risk of death is high due to sudden airway obstruction and difficulty intubating patients with extensive swelling of supraglottic structures.
- The adult mortality rate is around 7%.
- Mortality rate in pediatric cases is less than 1%.
Sex
- The male-to-female ratio is approximately 3:1.
Age
- Average age among adults is approximately 45 years.
- The condition is now more common in adults than in children in the United States.
- In the pediatric population, epiglottitis is most common in those aged 3-7 years, although any age may be affected.
History
The onset and progression of symptoms is rapid (George Washington woke up with a sore throat and died that night.). Although, in adolescents and adults, a less fulminant presentation is frequently demonstrated.
Historically, acute epiglottitis was most common in children aged 2-4 years. Since the introduction of the Hib vaccine and the accompanying dramatic reduction in H influenzae type B invasive disease incidence, epiglottitis has become rare in children. A comparison made between a large US children's hospital's chart review from 1995-2003 and a prior report from the same hospital done 27 years earlier, showed a 10-fold decline in acute epiglottitis admissions with streptococci becoming the major pathogens. Epiglottitis incidence in adults has remained constant.
In a 2005 retrospective review of patients with acute epiglottitis; symptoms of stridor, voice muffling, rapid clinical course, and a history of diabetes mellitus were significantly associated with the need for airway intervention.
- Sore throat (95%)
- Odynophagia/dysphagia (95%)
- Muffled voice (54%)
- Usually, no prodromal symptoms occur in children. Adults may have preceding upper respiratory infection (URI) symptoms.
Physical
- Fever
- Drooling/inability to handle secretions
- Cervical adenopathy
- Stridor - A late finding indicating advanced airway obstruction
- Muffled voice (54%)
- Tripod position - Sitting up on hands with the tongue out and the head forward
- Hypoxia
- Respiratory distress
- Severe pain on gentle palpation over larynx
- Mild cough
- Fever
- Irritability
- Tachycardia
- Toxic appearance of patient
Causes
- In adults with acute epiglottitis, blood cultures for H influenzae are positive in about 25% of cases. In remaining adult cases, Haemophilus parainfluenzae, Streptococcus pneumoniae, and group A streptococci are frequently isolated from pharyngeal cultures.
- Less common etiologies include other bacteria (eg, Staphylococcus aureus, mycobacteria, Bacteroides melaninogenicus, Enterobacter cloacae, Escherichia coli, Fusobacterium necrophorum, Klebsiella pneumoniae, Neisseria meningitidis, Pasteurella multocida), herpes simplex virus (HSV), other viruses, infectious mononucleosis, Candida (in immunocompromised patients), Aspergillus (in immunocompromised patients), thermal causes (including those associated with crack cocaine smoking and marijuana smoking), and caustic insults.
- Before widespread Hib vaccination, H influenzae caused almost all pediatric cases.
Other Problems to be Considered
Airway obstruction
Aspirated foreign body
Bacterial tracheitis
Caustic ingestions
Laryngitis
Sepsis
Lab Studies
- For those in extremis, samples for laboratory tests should not be drawn and epiglottic swab culture should not be obtained until the airway has been secured. Most adults present in a less acute fashion, and immediate testing is appropriate.
- Epiglottic swab
- Blood culture - Positive in approximately 25% of adult cases
Imaging Studies
- Radiographic evaluation for suspected epiglottitis is being replaced by direct visualization of the epiglottis using nasopharyngoscopy as the preferred method of diagnosis.
- For presentations in extremis, avoid radiography until the airway is secure because of the danger of sudden obstruction.
- Most adults can safely undergo imaging. In evaluating stable patients with suspected epiglottitis, lateral neck soft tissue radiographs are useful screening tools. Perform radiography with portable equipment, if indicated; this may confirm the diagnosis.
- The epiglottis is usually 3-5 mm in thickness; in one study of 30 patients with epiglottitis, using a criteria of 7-mm thickness provided 100% sensitivity and specificity.
- Another useful tool in differentiating epiglottitis is to examine the vallecula. To locate the vallecula, use a soft tissue lateral neck radiograph taken while the patient's mouth is closed. The hyoid is the air pocket found at the level of the hyoid bone just anterior to the epiglottis. To locate the hyoid, trace from the tongue base to the level of the hyoid bone. The vallecula is normally well delineated, deep, and roughly parallel to the pharyngotracheal air column. Identification of an abnormal-appearing vallecula on neck radiograph allows the clinician to more accurately interpret the presence of epiglottitis.
- Chest radiography
- Avoid until the patient's airway is secure.
- Obtain chest radiograph (CXR) for endotracheal tube (ET) placement.
- CXR may reveal pneumonia.
- Initial study regarding the applicability of using bedside ultrasonography in the evaluation of the normal epiglottis found it to be both easy to perform and accurate. Further analysis regarding usage of bedside ultrasonography in evaluating epiglottic disease and pathologic epiglottic enlargement may help to determine if there will be a future clinical role for ultrasonography in caring for acute epiglottitis.
Procedures
- Consider nasopharyngoscopy for patients who are not in extremis and when epiglottitis diagnosis is suspected.
- Orotracheal intubation may be required with little warning.
- Cricothyrotomy may be necessary for any patient with epiglottitis. Patients may deteriorate precipitously, and airway equipment, including that for cricothyrotomy, should be present in the patient's bay. Needle-jet insufflation (also known as percutaneous transtracheal jet ventilation [PTJV]) also may be considered to ventilate the patient temporarily. In cases of initial failure to intubate by direct laryngoscopy, PTJV may facilitate success in subsequent attempts at tracheal intubation by direct laryngoscopy. PTJV can produce high intratracheal pressures that appear to lift up and open the glottis with escape of the pressurized gasses causing the glottis edges to flutter, thereby allowing improved identification of the glottic aperture.
Prehospital Care
- Do not attempt intubation in the field unless acute airway obstruction is present.
- In the event of respiratory failure or obstruction, if Emergency Medical Services (EMS) is unable to intubate, then cricothyroidotomy or needle-jet insufflation are the next lines of treatment.
Emergency Department Care
- Some authors have tried to grade degrees of epiglottitis severity to guide treatment. A patient in extremis requires immediate airway management. Signs and symptoms associated with a need for intubation include respiratory distress, stridor, inability to swallow, sitting erect, and deterioration within 8-12 hours. When in doubt, securing the airway is likely the safest approach.
- Intubation or immediate formal tracheostomy or cricothyrotomy may be performed in the operating room if the case is less severe.
- Patients without signs of airway compromise may be managed without immediate airway intervention by close monitoring in the ICU.
- Avoid agitating the patient with acute epiglottitis. Let the patient take a position in which he or she feels comfortable.
- Administer supplemental humidified oxygen if possible, but do not force the patient as the resultant agitation could worsen the condition.
- Equipment for intubation, cricothyroidotomy, or needle-jet ventilation should be available at the bedside.
- An anesthesiologist and an ear, nose, and throat (ENT) specialist or a general surgeon should be notified as soon as possible in case of emergency or if operative management is anticipated. Early anesthesiologist and otolaryngologist consultation facilitates initial safe airway management, which is then followed by appropriate antibiotic treatment.
- Avoid therapy such as sedation, inhalers, or racemic epinephrine.
Consultations
- Consult an anesthesiologist and ENT specialist or general surgeon.
Antibiotic therapy should begin after blood and epiglottic cultures have been obtained. Antipyretics may be necessary. Racemic epinephrine, steroids, and beta-agonists have not been shown to be helpful.
Drug Category: Antibiotics
Empiric coverage for group A Streptococcus pneumoniae, Staphylococcus pyogenes, and H influenzae should be provided (a third-generation cephalosporin or amoxicillin/clavulanic acid).
| Drug Name | Ceftriaxone (Rocephin) |
| Description | DOC; third-generation cephalosporin with broad-spectrum activity against gram-negative organisms, lower efficacy against gram-positive organisms, and higher efficacy against resistant organisms. By binding to one or more penicillin-binding proteins, it arrests bacterial cell wall synthesis and bacterial growth. |
| Adult Dose | 1-2 g IV bid |
| Pediatric Dose | 75 mg/kg/d IV |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid may increase ceftriaxone levels; coadministration with ethacrynic acid, furosemide, and aminoglycosides may increase nephrotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Adjust dose in renal impairment; caution in breastfeeding and allergy to penicillin |
| Drug Name | Ampicillin (Omnipen, Marcillin) |
| Description | Alternative agent; interferes with bacterial cell wall synthesis during active replication, causing bactericidal activity against susceptible organisms.
|
| Adult Dose | 100 mg/kg/d PO divided qid |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction |
| Drug Name | Chloramphenicol (Chloromycetin) |
| Description | If allergic to penicillin and cephalosporins. Binds to 50S bacterial-ribosomal subunits and inhibits bacterial growth by inhibiting protein synthesis. Effective against gram-negative and gram-positive bacteria. |
| Adult Dose | 50-100 mg/kg/d PO divided qid |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Concurrently with barbiturates, chloramphenicol serum levels may decrease while barbiturate levels may increase causing toxicity; manifestations of hypoglycemia may occur with sulfonylureas; rifampin may reduce serum levels, presumably through hepatic enzyme induction; may increase effects of anticoagulants; may increase serum hydantoin levels, possibly resulting in toxicity; chloramphenicol levels may be increased or decreased |
| Pregnancy | C - Safety for use during pregnancy has not been established.
|
| Precautions | Use only for indicated infections or as prophylaxis for bacterial infections; serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia, thrombocytopenia, granulocytopenia) can occur; evaluate baseline and perform periodic blood studies approximately every 2 d while in therapy; discontinue upon appearance of reticulocytopenia, leukopenia, thrombocytopenia, anemia, or findings attributable to chloramphenicol; adjust dose in liver or kidney dysfunction; caution in pregnancy at term or during labor because of potential toxic effects on fetus (gray syndrome) |
Drug Category: Analgesic-antipyretics
These agents are helpful in relieving associated lethargy, malaise, and fever associated with the disease.
| Drug Name | Aspirin (Anacin, Ascriptin, Bayer Aspirin) |
| Description | Blocks prostaglandin synthetase action, which, in turn, inhibits prostaglandin synthesis and prevents formation of platelet-aggregating thromboxane A2. Acts on the hypothalamus heat-regulating center to reduce fever. Dissipation of heat is enhanced by vasodilating peripheral vessels, causing a decrease in body temperature. |
| Adult Dose | 325-650 mg PO q4-6h; not to exceed 4 g/d |
| Pediatric Dose | 10-15 mg/kg/d PO q4-6h; not to exceed 60-80 mg/kg/d |
| Contraindications | Documented hypersensitivity; liver damage; hypoprothrombinemia; vitamin K deficiency; bleeding disorders; anticoagulant use; severe anemia; asthma; because of association of aspirin with Reye syndrome, do not use in children ( <16 y) with flu |
| Interactions | Effects may decrease with antacids and urinary alkalinizers; corticosteroids decrease salicylate serum levels; additive hypoprothrombinemic effects and increased bleeding time may occur with coadministration of anticoagulants; may antagonize uricosuric effects of probenecid and increase toxicity of phenytoin and valproic acid; doses > 2 g/d may potentiate glucose-lowering effect of sulfonylurea drugs |
| Pregnancy | C - Safety for use during pregnancy has not been established.
|
| Precautions | Category D in third trimester of pregnancy; may cause transient decrease in renal function and aggravate chronic kidney disease |
| Drug Name | Acetaminophen (Tylenol, Panadol, Aspirin-Free Anacin) |
| Description | DOC for treating pain in patients with documented hypersensitivity to aspirin or NSAIDs, with upper GI disease, or who take oral anticoagulants. Reduces fever by a direct action on hypothalamic heat-regulating centers, which increases dissipation of body heat via vasodilation and sweating. |
| Adult Dose | 325-650 mg PO q4-6h or 1000 mg tid/qid; not to exceed 4 g/d |
| Pediatric Dose | <12 years: 10-25 mg PO q4-6h prn; not to exceed 2.6 g/d >12 years: 325-650 mg PO q4h; not to exceed 5 doses q24h |
| Contraindications | Documented hypersensitivity; known G-6-PD deficiency |
| Interactions | Rifampin can reduce analgesic effects of acetaminophen; coadministration with barbiturates, carbamazepine, hydantoins, and isoniazid may increase hepatotoxicity |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Hepatotoxicity possible in chronic alcoholics following various dose levels; severe or recurrent pain or high or continued fever may indicate a serious illness; contained in many OTC products and combined use with these products may result in cumulative doses exceeding recommended maximum dose |
| Drug Name | Ibuprofen (Ibuprin, Advil, Motrin) |
| Description | Usually the DOC for treating mild to moderate pain, if no contraindications exist. Inhibits inflammatory reactions and pain, probably by decreasing the activity of cyclooxygenase enzyme, which inhibits prostaglandin synthesis. One of the few NSAIDs indicated for reduction of fever. |
| Adult Dose | 200-400 mg PO q4-6h while symptoms persist; not to exceed 3.2 g/d |
| Pediatric Dose | <6 months: Not established 6 months to 12 years: 20-40 mg/kg/d PO divided tid/qid >12 years: Administer as in adults |
| Contraindications | Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding |
| Interactions | Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently |
| Pregnancy | B - Usually safe but benefits must outweigh the risks.
|
| Precautions | Category D in third trimester of pregnancy; caution in congestive heart failure, hypertension, and decreased renal and hepatic function; caution in anticoagulation abnormalities or during anticoagulant therapy |
Further Inpatient Care
- Watch for air leaks around the endotracheal tube.
- Laryngoscopy is recommended prior to extubation. An ENT specialist and an anesthesiologist should be immediately available.
Deterrence/Prevention
- Close contacts of patients in whom Haemophilus influenzae type B is isolated should receive rifampin prophylaxis (20 mg/kg; not to exceed 600 mg/d for 4 d).
- H influenzae vaccine is available but not 100% effective.
- Occurrence of recurrent episodes of acute epiglottitis in adults is unusual and, when present, warrants immune system investigation since a quantitative or specific antibiotic deficiency may be present. Treatment of patients with recurrent acute epiglottitis may involve immunization or antibody replacement.
Complications
- Pulmonary edema
- Epiglottic abscess
- Pneumonia
- Meningitis
- Cervical adenitis
- Septic arthritis
- Pericarditis
- Cellulitis
- Septic shock
- Vocal granuloma
- Pneumothorax
- Pneumomediastinum (rare)
- Subsequent necrotizing fasciitis of the head and neck (rare)
- Death (asphyxia)
Prognosis
- Most patients can be extubated within several days.
- Good prognosis with appropriate treatment
Patient Education
Medical/Legal Pitfalls
- Underestimating the potential for sudden deterioration (most common error)
- Inadequate monitoring in which deterioration goes unnoticed (second most common error)
- Rushing intubation without proper support (ENT available)
- Performing unnecessary medical procedures that result in agitation and respiratory collapse
- Obtaining unnecessary radiographs when diagnosis can be made by history and physical examination alone or with nasopharyngoscopy
| Media file 1:
Soft-tissue lateral neck radiograph reveals edema of epiglottis consistent with acute epiglottitis. |
 | View Full Size Image | |
Media type: X-RAY
|
- Berg S, Trollfors B, Nylen O, et al. Incidence, aetiology, and prognosis of acute epiglottitis in children and adults in Sweden. Scand J Infect Dis. 1996;28(3):261-4. [Medline].
- Caballero M, Sabater F, Traserra J, et al. Epiglottitis and necrotizing fasciitis: a life-threatening complication of infectious mononucleosis. Acta Otolaryngol. Oct 2005;125(10):1130-3. [Medline].
- Carey MJ. Epiglottitis in adults. Am J Emerg Med. Jul 1996;14(4):421-4. [Medline].
- Chan KO, Pang YT, Tan KK. Acute epiglottitis in the tropics: is it an adult disease?. J Laryngol Otol. Sep 2001;115(9):715-8. [Medline].
- Chandradeva K, Palin C, Ghosh SM, Pinches SC. Percutaneous transtracheal jet ventilation as a guide to tracheal intubation in severe upper airway obstruction from supraglottic oedema. Br J Anaesth. May 2005;94(5):683-6. [Medline].
- Ducic Y, Hebert PC, MacLachlan L, et al. Description and evaluation of the vallecula sign: a new radiologic sign in the diagnosis of adult epiglottitis. Ann Emerg Med. Jul 1997;30(1):1-6. [Medline].
- Faden H. The dramatic change in the epidemiology of pediatric epiglottitis. Pediatr Emerg Care. Jun 2006;22(6):443-4. [Medline].
- Gagnon R, Bedard PM, Cote L, et al. Recurrent acute epiglottitis in adults: defective antibody response. Ann Allergy Asthma Immunol. May 2002;88(5):513-7. [Medline].
- Gerber AC, Pfenninger J. Acute epiglottitis: management by short duration of intubation and hospitalisation. Intensive Care Med. 1986;12(6):407-11. [Medline].
- Katori H, Tsukuda M. Acute epiglottitis: analysis of factors associated with airway intervention. J Laryngol Otol. Dec 2005;119(12):967-72. [Medline].
- Kornak JM, Freije JE, Campbell BH. Caustic and thermal epiglottitis in the adult. Otolaryngol Head Neck Surg. Feb 1996;114(2):310-2. [Medline].
- Werner SL, Jones RA, Emerman CL. Sonographic assessment of the epiglottis. Acad Emerg Med. Dec 2004;11(12):1358-60. [Medline].
- Wetmore RF, Handler SD. Epiglottitis: evolution in management during the last decade. Ann Otol Rhinol Laryngol. Nov-Dec 1979;88(Pt 1):822-6. [Medline].
- Wick F, Ballmer PE, Haller A. Acute epiglottis in adults. Swiss Med Wkly. Oct 12 2002;132(37-38):541-7. [Medline].
- Yong MG, Choo MJ, Yum CS, et al. Radiologic laryngeal parameters in acute supraglottitis in Korean adults. Yonsei Med J. Aug 2001;42(4):367-70. [Medline].
Epiglottitis, Adult excerpt Article Last Updated: Dec 11, 2006
|